Endometrial carcinogenesis induced by concurrent oral administration of ethylenethiourea and sodium nitrite in mice.
Endometrial carcinogenesis induced by concurrent oral administration of ethylenethiourea (ETU) and sodium nitrite (NaNO2) was investigated in ICR (Crj:CD-1) female mice. A mixed solution of ETU (100 mg/kg) and NaNO2 (70 mg/kg) was given to animals orally once a week for up to 6 months and all surviving animals were killed at 12 months of study. During the study, estrous cycle was monitored by vaginal smear and five or 10 selected animals were subjected to interim killing at 3 month interval to observe time-related carcinogenic responses of the uterus. Treatment with ETU and NaNO2 resulted in development of endometrial adenocarcinomas in the uterine horn and the incidence reached 42% in the surviving animals at 12 months. Prior to the development of the tumor, atypical hyperplasia of endometrial glands was frequently observed and regarded as the precancerous lesion. Immunohistochemistry for bromodeoxyuridine (BrdU) incorporation revealed higher labeling indices in both hyperplastic and neoplastic endometrial glandular cells, and the index in the adenocarcinoma was more than 20% on average at any stage of the estrous cycle. Overexpression of p53 protein, which is frequently demonstrated in virulent phenotypes of human corpus cancers, was seen in three out of eight (38%) adenocarcinomas, but not in the atypical hyperplasia or normal endometrial glands. There were no treatment-related changes in the estrous cycle on vaginal smears at any interval of the study. The analyses for plasma ovarian hormones at 12 months disclosed a marked depression of progesterone in the treated animals, while the 17 beta-estradiol (E2) level was comparable to the controls. These results suggest that endometrial carcinogenesis by ETU and NaNO2 could be initiated with atypical hyperplasia of the endometrial gland and a decrease in plasma progesterone level may play an important role in the development of endometrial carcinogenesis. In addition, inactivation of the p53 gene may play a significant role in the malignant transformation of endometrial epithelial cells in mice.
Yoshida
A
A
Toxicology Division, Mitsukaido Laboratories, Institute of Environmental Toxicology, Ibaraki, Japan.
Harada
T
T
Hayashi
S
S
Mori
I
I
Miyajima
H
H
Maita
K
K
D000230:Adenocarcinoma / Q000139:chemically induced*; D000284:Administration, Oral; D000818:Animals; D001973:Bromodeoxyuridine / Q000378:metabolism; D003043:Cocarcinogenesis; D016889:Endometrial Neoplasms / Q000139:chemically induced*; D004971:Estrus / Q000502:physiology; D005031:Ethylenethiourea / Q000633:toxicity*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D007150:Immunohistochemistry; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D010053:Ovary / Q000502:physiology; D012977:Sodium Nitrite / Q000633:toxicity*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D014599:Uterus / Q000033:anatomy & histology / Q000187:drug effects; D014621:Vagina / Q000502:physiology; D014626:Vaginal Smears
D012739:Gonadal Steroid Hormones; D016159:Tumor Suppressor Protein p53; D005031:Ethylenethiourea; D001973:Bromodeoxyuridine; D012977:Sodium Nitrite